Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
30
Apr |
IOM Calls On Physicians To Reject Financial Arrangements With DrugmakersCategory: Primary Care / General Practice | Leave a Comment |
The Institute of Medicine on Tuesday issued a set of guidelines that call on physicians, medical professionals in academia and health service providers to make public all payments and gifts they receive from the drug and medical device industries, the New York Times reports (Harris, New York Times, 4/29).
|
30
Apr |
Potential New Weapon Against Brain Cancer - NASA’s Electronic NoseCategory: Neurology / Neuroscience | Leave a Comment |
An unlikely multidisciplinary scientific collaboration has discovered that an electronic nose developed for air quality monitoring on Space Shuttle Endeavour can also be used to detect odour differences in normal and cancerous brain cells. The results of the pilot study open up new possibilities for neurosurgeons in the fight against brain cancer.
|
30
Apr |
Sylvester Comprehensive Cancer Center At UM First In Miami To Offer “GPS For The Body(R)”Category: Prostate / Prostate Cancer | Leave a Comment |
Sylvester Comprehensive Cancer Center, part of UHealth-University of Miami Health System, announced it is the first cancer-care program in the region enabling clinicians to accurately manage delivery of radiation to prostate cancer tumors through a new technology called the Calypso® 4D Localization System™. The System enables precision-guided radiation therapy delivery to the prostate with continuous, objective, organ-motion detection and monitoring.
|
30
Apr |
Star Trek-like System Offers Noninvasive Monitor For PatientsCategory: Medical Devices / Diagnostics | Leave a Comment |
How long will it take to develop Star Trek-like medical technologies? The gap between science fiction and reality is closing faster than many people may think. A noninvasive, needle-free system that uses light to measure tissue oxygen and pH will soon be an alternative to the painful use of needles to draw blood and cumbersome equipment to determine metabolic rate. The futuristic system, dubbed the Venus prototype, is being developed by Dr. Babs Soller and her colleagues.
|
30
Apr |
DxNA To Use Its Rapid Detection Platform To Simplify Testing For Swine Flu (H1N1 Virus)Category: Swine Flu | Leave a Comment |
DxNA announced that in response to the recent outbreak of swine flu and related world threat, it is developing a diagnostic test for its GeneSTAT(R) pathogen detection platform to detect the H1N1 virus (known as swine flu) anywhere it is needed in approximately 45 minutes using a portable device that weighs less than 10 pounds. The Company anticipates having a product ready for evaluation in 1-2 weeks.
|
30
Apr |
Germgard’s Ultra-Fast Hand Hygiene Solution Protects Against Deadly MRSA, C Difficile, And Influenza VirusCategory: MRSA / Drug Resistance | Leave a Comment |
In an effort to provide technology to reduce healthcare-associated infections, Germgard Lighting LLC, a New Jersey-based early-phase medical device company, has demonstrated its patented ultra-fast (~1 second) hand hygiene solution. The solution is designed to protect hospital patients and medical professionals from exposure to dangerous, life-threatening pathogens in healthcare facilities. It enables effective, frequent and instantaneous hygiene practice at the immediate point of care.
|
30
Apr |
Stroke Predictors Identified In Black PatientsCategory: Stroke | Leave a Comment |
Predictors of atrial fibrillation (AF or afib) might offer physicians a better way to prevent stroke in blacks, according to a new study done by researchers at Wake Forest University School of Medicine. AF is an irregular and often rapid heart rate that commonly causes poor blood flow to the body, as well as symptoms of heart palpitations, shortness of breath and weakness.
|
30
Apr |
CME: AspergillosisCategory: Medic | Leave a Comment |
(No abstract is available for this citation)
|
30
Apr |
CME: Asthma in PregnancyCategory: Medic | Leave a Comment |
(No abstract is available for this citation)
|
30
Apr |
CME: Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionCategory: Medic | Leave a Comment |
(No abstract is available for this citation)